无干扰素抗病毒治疗后丙型肝炎病毒清除但仍存在持续性混合性冷球蛋白血症性血管炎 - Suppr

Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy.

作者信息

Sollima Salvatore, Milazzo Laura, Peri Anna Maria, Torre Alessandro, Antinori Spinello, Galli Massimo

机构信息

III Division of Infectious Diseases, L. Sacco University Hospital

III Division of Infectious Diseases, L. Sacco University Hospital.

出版信息

Rheumatology (Oxford). 2016 Nov;55(11):2084-2085. doi: 10.1093/rheumatology/kew268. Epub 2016 Jun 23.

DOI:10.1093/rheumatology/kew268

PMID:27338085

Abstract

摘要

相似文献

Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy.

Rheumatology (Oxford). 2016 Nov;55(11):2084-2085. doi: 10.1093/rheumatology/kew268. Epub 2016 Jun 23.

Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus.

J Rheumatol. 2005 Jun;32(6):1164-7.

PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.

J Hepatol. 2015 Jan;62(1):24-30. doi: 10.1016/j.jhep.2014.08.015. Epub 2014 Aug 15.

Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study.

Dig Liver Dis. 2014 Sep;46(9):833-7. doi: 10.1016/j.dld.2014.05.017. Epub 2014 Jun 19.

Recurrence of mixed cryoglobulinaemia vasculitis following influenza vaccination despite clearance of hepatitis C virus infection.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):161-162. Epub 2017 Nov 21.

Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer.

Rheumatology (Oxford). 2018 Oct 1;57(10):1870-1871. doi: 10.1093/rheumatology/key157.

Persistent mixed cryoglobulinemia after successful antiviral treatment of chronic hepatitis C virus infection: What's the next?

Scand J Gastroenterol. 2018 Jun-Jul;53(7):883-884. doi: 10.1080/00365521.2018.1477988. Epub 2018 Jul 2.

Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.

Curr Opin Rheumatol. 2008 Jan;20(1):23-8. doi: 10.1097/BOR.0b013e3282f1330c.

Cryoglobulinemia-related vasculitis during effective anti-HCV treatment with PEG-interferon alfa-2b.

Infection. 2008 Jun;36(3):285-7. doi: 10.1007/s15010-007-6299-1. Epub 2007 Oct 25.

Symptomatic and virological response to antiviral therapy in hepatitis C associated with extrahepatic complications of cryoglobulimia.

Dig Dis Sci. 2007 Sep;52(9):2410-7. doi: 10.1007/s10620-006-9355-2. Epub 2007 Apr 6.

引用本文的文献

Direct-Acting Antivirals and Risk of Hepatitis C Extrahepatic Manifestations.

JAMA Netw Open. 2025 Jun 2;8(6):e2514631. doi: 10.1001/jamanetworkopen.2025.14631.

Hepatitis C associated mixed cryoglobulinemia glomerulonephritis in the setting of undetectable viral load: successful treatment with hydroxychloroquine and review of the literature.

Immunol Res. 2025 Feb 21;73(1):55. doi: 10.1007/s12026-025-09608-7.

Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease.

Adv Kidney Dis Health. 2023 Jul;30(4):343-355. doi: 10.1053/j.akdh.2023.04.003.

Hepatitis C Virus-associated Cryoglobulinemic Livedo Reticularis Improved with Direct-acting Antivirals.

Intern Med. 2023 Dec 15;62(24):3631-3636. doi: 10.2169/internalmedicine.1671-23. Epub 2023 Apr 28.

Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection.

World J Hepatol. 2022 Jun 27;14(6):1053-1073. doi: 10.4254/wjh.v14.i6.1053.

Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study.

Front Immunol. 2022 Mar 8;13:823160. doi: 10.3389/fimmu.2022.823160. eCollection 2022.

A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort.

Hepatology. 2022 Jul;76(1):220-232. doi: 10.1002/hep.32281. Epub 2022 Jan 19.

Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis.

Hepatology. 2021 Sep;74(3):1164-1173. doi: 10.1002/hep.31804. Epub 2021 May 26.

Spectrum of Kidney Diseases in Patients With Hepatitis C Virus Infection.

Am J Clin Pathol. 2021 Aug 4;156(3):399-408. doi: 10.1093/ajcp/aqaa238.

Direct-acting antiviral therapy improves kidney survival in hepatitis C virus-associated cryoglobulinaemia: the RENALCRYOGLOBULINEMIC study.

Clin Kidney J. 2020 Jan 25;14(2):586-592. doi: 10.1093/ckj/sfz178. eCollection 2021 Feb.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献